NanOlogy
As of the edition of 20 October 2026, NanOlogy runs 1 drug; it is on route A at 15 targets and on route B at 0 targets.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Went quiet | 1 |
| Total | 1 |
Where it needs a new molecule
Route A at 15 targets, route B at 0 targets.
All 15 rows on route A or B
In the product15 company-target rows on route A or B; 12 are not shown here, and no score is.
See all 15 targets where NanOlogy needs a new molecule, with the facts behind eachRequest access. Nothing is shown until you do.
Where its trials are
- Cancer: 2 trials led
- Urinary and reproductive: 2 trials led
- Lungs and airways: 1 trials led